Related Experiment Video
Updated: Apr 22, 2026

08:22
Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
Published on: September 15, 2018
7.5K
Micro-RNA expression in hypoplastic left heart syndrome.
Carmen C Sucharov1, Juliana Sucharov2, Anis Karimpour-Fard3
1Division of Cardiology, Denver Department of Medicine, University of Colorado, Aurora, Colorado.
Journal of Cardiac Failure
|October 8, 2014
Summary
This study reveals a unique micro-RNA (miRNA) profile in hypoplastic left heart syndrome (HLHS) patients, distinct from adult heart conditions. These findings suggest specific miRNA roles in congenital heart defects and disease development.
Area of Science:
- Molecular Biology
- Genetics
- Pediatric Cardiology
Background:
- Micro-RNAs (miRNAs) regulate gene expression by interacting with messenger RNAs (mRNAs).
- Extensive research exists on miRNAs in adult heart disease, but less in congenital heart conditions.
- Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect impacting infants and children.
Purpose of the Study:
- To analyze the micro-RNA (miRNA) profile in pediatric patients diagnosed with hypoplastic left heart syndrome (HLHS).
- To identify potential miRNA targets involved in cardiac development and disease within HLHS.
- To investigate the relationship between miRNA expression and surgical intervention in HLHS.
Main Methods:
- Micro-RNA profiling using miRNA arrays in the right ventricle of HLHS patients.
- Validation of miRNA expression via reverse-transcription polymerase chain reaction (RT-PCR).
- Bioinformatic analysis to identify miRNA targets and subsequent expression analysis using RT-PCR.
Main Results:
- A novel miRNA profile was identified in HLHS, showing limited similarity to adult idiopathic dilated cardiomyopathy.
- Putative miRNA targets crucial for cardiac development and disease were identified.
- MiRNA expression demonstrated changes correlating with surgical stage, indicating the impact of ventricular volume unloading.
Conclusions:
- The study suggests a distinct miRNA signature associated with HLHS.
- This unique miRNA profile may play a role in the underlying defects of cardiac development and disease progression in HLHS.
Related Concept Videos
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs
20.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
795
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
795

